NCT04412486View on ClinicalTrials.gov

COVID-19 Convalescent Plasma (CCP) Transfusion

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

March 23, 2023

Study Completion Date

March 23, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

COVID Convalescent Plasma

One unit of COVID Convalescent Plasma transfused on Day 0

Trial Locations (1)

39216

University of Mississippi Medical Center, Jackson

All Listed Sponsors
collaborator

University of Mississippi Medical Center

OTHER

lead

Gailen D. Marshall Jr., MD PhD

OTHER

NCT04412486 - COVID-19 Convalescent Plasma (CCP) Transfusion | Biotech Hunter | Biotech Hunter